Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adagio Therapeutics (ADGI)
NASDAQ:ADGI
Adagio Therapeutics (ADGI) Stock Price & Analysis
0 Followers
ADGI Stock Chart & Stats
Day’s Range$4.4 - $4.74
52-Week Range― - ―
Previous Close$4.6
Volume536.35K
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding108,830,525
10 Day Avg. Volume475,308
30 Day Avg. Volume646,245
Standard Deviation0.38
R-Squared0.09
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)1.15
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Adagio Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ADGI FAQ
What was Adagio Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Adagio Therapeutics’s market cap?
Currently, no data Available
When is Adagio Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Adagio Therapeutics’s earnings last quarter?
Currently, no data Available
Is Adagio Therapeutics overvalued?
According to Wall Street analysts Adagio Therapeutics’s price is currently Overvalued.
Does Adagio Therapeutics pay dividends?
Adagio Therapeutics does not currently pay dividends.
What is Adagio Therapeutics’s EPS estimate?
Adagio Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Adagio Therapeutics have?
Currently, no data Available
What happened to Adagio Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Adagio Therapeutics?
Among the largest hedge funds holding Adagio Therapeutics’s share is Slate Path Capital LP. It holds Adagio Therapeutics’s shares valued at 12M.
---
Adagio Therapeutics Stock Smart Score
Learn more about TipRanks Smart Score
Company Description
Adagio Therapeutics
Adagio Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease 2019, or COVID-19, the disease caused by the virus SARS-CoV-2 and its variants.
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
---